期刊文献+

肿瘤细胞中HER2与脂肪酸合酶的关系 被引量:2

Review on Relationship Between HER2 and Fatty Acid Synthase in Tumor Cells
下载PDF
导出
摘要 脂肪酸代谢和机体的能量平衡与肿瘤发生发展密切相关。脂肪酸合成酶(fatty acid synthase,FASN)作为一个代谢性癌基因,是能量链中的核心分子。近年来不少研究发现FASN和人表皮生长因子受体2(human epidermal growth factor receptor 2,HER2)之间存在双向分子联系,共同促进癌细胞转化、增殖、侵袭、转移、耐药等。本文对肿瘤细胞中二者相互作用作一综述。 Fatty acid metabolism and the body’s energy balance are closely related to tumor development.Fatty acid synthase(FASN),as a metabolic oncogene,is the core of the energy chain molecules.In recent years,many studies have found that human epidermal growth factor receptor 2(HER2) establishes a bidirectional relationship with FASN,together to promote cancer cell transformation,proliferation,invasion,metastasis and drug resistance.This paper reviews on the relationship between FASN and HER2 in tumor cells.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2015年第6期614-617,共4页 Cancer Research on Prevention and Treatment
基金 国家青年自然科学基金(81201855) 广东高校优秀青年创新人才培养计划项目(2012LYM_0037)
关键词 人表皮生长因子受体2 脂肪酸合酶 肿瘤细胞 信号通路 Human epidermal growth factor receptor 2(HER2) Fatty acid synthase(FASN) Tumor cells Signal pathway
  • 相关文献

参考文献20

  • 1张妤,殷正丰.肿瘤细胞中脂肪酸合成酶和人表皮生长因子受体2的联系[J].第二军医大学学报,2007,28(11):1255-1258. 被引量:1
  • 2Xin-Hua Long,Guo-Mei Zhang,Ai-Fen Peng,Qing-Feng Luo,Lin Zhang,Hui?Cai Wen,Rong-Ping Zhou,Song Gao,Yang Zhou,Zhi-Li Liu.Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulationof the activity of the HER2-PI3K/AKT-FASN axis in vitro[J]. Oncology Reports . 2014 (1)
  • 3Nan Li,Xiaodong Bu,Xiaoqiang Tian,Peng Wu,Lin Yang,Peilin Huang.Fatty Acid Synthase Regulates Proliferation and Migration of Colorectal Cancer Cells Via HER2-PI3K/Akt Signaling Pathway[J]. Nutrition and Cancer . 2012 (6)
  • 4Nan Li,Xiaodong Bu,Peng Wu,Pingping Wu,Peilin Huang.The “HER2–PI3K/Akt–FASN Axis” Regulated Malignant Phenotype of Colorectal Cancer Cells[J]. Lipids . 2012 (4)
  • 5SDSilva,IWCunha,RNYounes,FASoares,LPKowalski,EGraner.ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas[J]. Oral Diseases . 2010 (8)
  • 6Javier A. Menendez.Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives[J]. BBA - Molecular and Cell Biology of Lipids . 2009 (3)
  • 7Thomas W. Grunt,Renate Wagner,Michael Grusch,Walter Berger,Christian F. Singer,Brigitte Marian,Christoph C. Zielinski,Ruth Lupu.Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells[J]. Biochemical and Biophysical Research Communications . 2009 (3)
  • 8Sabrina D. Silva,Isabela W. Cunha,Ana Lúcia C. A. Rangel,Jacks Jorge,Karina G. Zecchin,Michelle Agostini,Luiz P. Kowalski,Ricardo D. Coletta,Edgard Graner.Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes[J]. Virchows Archiv . 2008 (1)
  • 9A.Vazquez‐Martin,R.Colomer,J.Brunet,R.Lupu,J. A.Menendez.Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells[J]. Cell Proliferation . 2008 (1)
  • 10Sabrina D. Silva,Danyel E. Perez,Fabio A. Alves,Inês N. Nishimoto,Clóvis A.L. Pinto,Luiz P. Kowalski,Edgard Graner.ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: Correlation with clinical outcomes[J]. Oral Oncology . 2007 (5)

二级参考文献19

  • 1Kuhajda F P, Jenner K, Wood F D, et al. Fatty acid synthesis:a potential selective target for antineoplastic therapy[J]. Proc Natl Acad Sci USA,1994,91:6379-6383.
  • 2Wakil S J. Fatty acid synthase, a proficient multifunctional enzyme[J]. Biochemistry, 1989, 28: 4523-4530.
  • 3Weiss L, Hoffmann G E, Schreiber R, et al. Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fattyacid synthase[J]. Biol Chem Hoppe Seyler, 1986, 367: 905- 912.
  • 4Menendez J A, Lupu R. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolie-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells[J]. Arch Immunol Ther Exp (Warsz), 2004,52:414-426.
  • 5Kolibaba K S, Druker B J. Protein tyrosine kinases and cancer [J]. Biochim Biophys Acta, 1997, 1333: F217-F248.
  • 6Kumar-Sinha C, Ignatoski K W, Lippman M E, et al. Transeriptome analysis of HER2 reveals a molecular connection to fatty acid synthesi[J]. Cancer Res,2003,63:132-139.
  • 7Pan M H, Lin C C, Lin J K, et al. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-indueed fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling[J]. J Agric Food Chem,2007, 55:5030-5037.
  • 8Silva S D, Agostini M, Nishimoto I N, et al. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study[J]. Oral Oncol, 2004, 40: 688-696.
  • 9Sliehenmyer W J, Elliott W L, Fry D W. CI-1033, a pan-erbB tyrosine kinase inhibitor[J]. Semin Oneol, 2001,28 (5 Suppl 16) : 80-85.
  • 10Heemers H, Maes B, Foufelle F, et al. Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein eleavage activating protein/sterol regulatory element-binding protein pathway [J]. Mol Endocrinol,2001,15: 1817-1828.

同被引文献11

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部